Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells
Background and objective Angiogenesis is an important process in the development of tumor. PD 0332991, a cell cycle inhibitor, can specifically inhibit CD4/6 phosphorylation and cell cycle progression. In xeongraft mice models, PD 0332991 treated mice had significantly decreased angiogenesis and vas...
Main Authors: | Chenlong ZHAO, Minghui LIU, Yongwen LI, Hongbing ZHANG, Ying LI, Hao GONG, Yin YUAN, Weiting LI, Hongyu LIU, Jun CHEN |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-05-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.05.04 |
Similar Items
-
PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
by: Minghui Liu, et al.
Published: (2021-03-01) -
CDK4/6 inhibitor PD0332991 in glioblastoma treatment: does it have a future?
by: Lisette eSchroder, et al.
Published: (2015-11-01) -
Profile of palbociclib in the treatment of metastatic breast cancer
by: Ehab M, et al.
Published: (2016-05-01) -
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines
by: Graziana Digiacomo, et al.
Published: (2020-09-01) -
Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids
by: Mingbiao LI, et al.
Published: (2016-12-01)